Purpose: On computed tomography (CT), intrahepatic cholangiocarcinomas (ICC) are a visibly heterogeneous group of tumors. The purpose of this study was to investigate the associations between CT imaging phenotypes, patient survival, and known genetic markers. Methods: A retrospective study was performed with 66 patients with surgically resected ICC. Pre-surgical CT images of ICC were assessed by radiologists blinded to tumor genetics and patient clinical data. Associations between qualitative imaging features and overall survival (OS) and disease-free survival (DFS) were performed with Cox proportional hazards regression and visualized with Kaplan-Meier plots. Associations between radiographic features and genetic pathways (IDH1, Chromatin and RAS-MAPK) were assessed with Fisher's Exact test and the Wilcoxon Rank sum test where appropriate and corrected for multiple comparisons within each pathway using the False Discovery Rate correction. Results: Three imaging features were significantly associated with a higher risk of death: necrosis (hazard ratio (HR) 2.95 95% CI 1.44-6.04, p = 0.029), satellite nodules (HR 3.29, 95% CI:1.35-8.02, p = 0.029), and vascular encasement (HR 2.63, 95% CI 1.28-5.41, p = 0.029). Additionally, with each increase in axial size, the risk of death increased (HR 1.14, 95% CI 1.03-1.26, p = 0.029). Similar to findings for OS, satellite nodules (HR 3.81, 95% CI 1.88-7.71, p = 0.002) and vascular encasement (HR 2.25, 95% CI 1.24-4.06, p = 0.019) were associated with increased risk of recurrence/death. No significant associations were found between radiographic features and genes in the IDH1, Chromatin or RAS-MAPK pathways (p = 0.63-84). Conclusion: This preliminary analysis of resected ICC suggests associations between CT imaging features and OS and DFS. No association was identified between imaging features and currently known genetic pathways.
quantitative features can be performed to convert images into mineable data to be analyzed for prognostic biomarkers, a process termed radiomics [9] . Alternatively, qualitative evaluations by radiologists using a standard lexicon may also be used to annotate images prospectively and contribute to mineable databases, for example, by using terminology developed by the Liver Imaging Reporting and Data System (LI-RADS) [10] .
Among ICCs, a range of imaging appearances are evident, from small hypervascular tumors mimicking HCC, to larger tumors with desmoplastic centers, as well as infiltrative and necrotic appearing ICC [2] . Qualitative descriptors of ICC may have prognostic value, as a number of studies have identified the potential of tumoral vascularity in differentiating short-and long-term survivors [11] [12] [13] [14] .
Given the imaging heterogeneity of ICC observable on CT and MRI, and recent advances in our genetic understanding of this tumor [15] [16] [17] [18] , we hypothesized that qualitative descriptors of ICC may correlate with different genetic subtypes of ICC. The purpose of our study was to correlate radiologic phenotypes of ICC on contrast enhanced CT with known genetic pathways and survival outcomes in surgical patients.
Materials and methods

Patient population
The study was approved by our Institutional Review Board and was compliant with the Health Insurance Portability and Accountability Act. A retrospective review was performed to identify patients with resected mass-forming ICC from January 1993 to December 2014, who had genetic mutation profiling and available pre-surgical CT imaging available for evaluation on a picture archiving and communications system (PACS -GE Centricity, Milwaukee, WI). Pathologic specimens included surgical tissue resections (n = 63 cases) and core biopsy samples (n = 3 cases). Before treatment, patients had given informed consent for review of medical records, imaging, pathologic and genetic data for correlated research. 61 of 66 (92%) patients had no prior therapy prior to tumor sampling, with the remaining five receiving chemotherapy.
CT Image Acquisition
The CT studies selected for review were the most recently acquired study prior to the specimen date, including both CTs performed at our own institution (n = 51, 77%) and those performed at other institutions (n = 15, 23%), all uploaded to PACS as complete Digital Imaging and Communication in Medicine (DICOM) imaging set. These CT studies were performed on a variety of scanner models all with multidetector CT (16-64 slices) and included single-phase (n = 12, 18%) and multi-phase postcontrast imaging (n = 54, 82%). Arterial phase imaging was available in 52/66 CTs. Delayed phase imaging was available in 6 CTs. All scans had maximal axial slice thicknesses of 5 mm.
Image analysis
Imaging features were reviewed in consensus by EA and RD, who were blinded to clinical and genomic data. The radiologists were aware that each patient had a pathologically proven ICC.
Lesion size was measured on the imaging phase on which the lesion was most clearly delineated both as the largest axial size and the perpendicular axial size (or short axis). The presence or absence of the following LI-RADS imaging features (v 2014) was assessed: washout appearance, mosaic architecture, disproportionate biliary obstruction, central necrosis, liver surface retraction, tumor in vein. Other imaging features included in the analysis were lesion border (well defined or infiltrative), enhancement pattern (homogeneous or heterogeneous), central fibrosis, vascular encasement without thrombus (present or absent), hepatolithiasis (present or absent), perilesional perfusional abnormality (present or absent), satellite nodules-defined as tumors within 1 cm of the primary tumor border (present or absent), intrahepatic metastases-defined as tumors > 1 cm from the primary tumor (present or absent) and adenopathy (absent-short axis < 1.0 cm, present-short axis ‡ 1.0 cm and non-specific, or present and suspicious for nodal metastases) (Fig. 1 ).
Genetic analysis
Genetic mutation profiling was completed using the MSK-IMPACT assay, a customized array of 341 cancer-associated genes with subsequent expansion to 410 cancer-associated genes [19] . The most commonly occurring genetic alterations were identified and grouped by previously identified cancer pathways and families as follows: IDH1, chromatin remodeling gene family (BAP2, ARID1A, PBRM1), and KRAS/RASA1 [20] [21] [22] .
Statistical analysis
Radiologic characteristics were summarized, and continuous characteristics and categorical characteristics with at least 10 patients in each category were considered for analysis. The associations between radiologic features and genetic pathways were assessed with Fisher's Exact test and the Wilcoxon Rank Sum test, where appropriate, and corrected for multiple comparisons within each pathway using the False Discovery Rate correction.
Adjusted p values less than 0.05 were considered for multivariate analysis.
We also compared radiographic features to overall (OS) and disease-free (DFS) survival with Cox proportional hazards regression. OS was calculated from the time of resection until death. Patients alive at last followup were censored. DFS was calculated from resection until recurrence or death. Patients alive and disease free at last follow-up were censored. Univariate p values were corrected using the false discovery rate approach (FDR), and adjusted p values less than 0.05 were considered for multivariate analysis. Multicollinearity was examined. The multivariate model discrimination ability was assessed with Gonen and Heller's K, also known as the Concordance Probability Estimate. All analyses were performed with SAS 9.4 (The SAS Institute, Cary, NC).
Results
Patient characteristics and radiologic features
Sixty-six patients (41 female, 25 male) met the inclusion criteria with a median age at diagnosis of 64.5 years (range 29-87 years). Tumor sizes ranged from 1.6 to 15.9 cm in maximal axial dimension (Table 1) . A majority of ICC had well-defined borders (n = 55, 83%) with heterogeneous enhancement patterns (n = 60, 90.9%), and lacked evidence of central necrosis (n = 41, 62.1%) ( Table 1) . A minority of our patients had evidence of advanced disease, such as adenopathy (n = 23, 34.9%), satellite nodule (n = 12, 18.2%), intrahepatic metastasis (n = 4, 6.1%), and tumor in vein (n = 1, 1.5%). Of the 23 patients with adenopathy, 11 were assessed as suspicious for nodal metastases (16.7%) and 12 were deemed non-specific (18.2%). 
Correlation with gene pathways
Median time between CT and IMPACT was 0.6 months (range 0.1-6.2 months). The most commonly identified families and pathways, which were expressed in 10 or more patients in our study population, were IDH1, Chromatin remodeling gene family, and KRAS/RASA1 pathways (manuscript in preparation by (blinded for review)). No significant associations were found between radiologic imaging features and genes in the IDH1 pathway (p = 0.70 to > 0.95), Chromatin remodeling Pathway (p = 0.59 to > 0.95), or KRAS/RASA1 pathway (p = 0.63-84) ( Table 2) .
Correlation with survival
Overall, median OS was 53 months (95% CI 43-79) with a 5-year OS of 48% (95% CI 33-62%), and median DFS was 17 months (95% CI 10-33) with a 5-year DFS of 26% (95% CI 16-38%). In survivors, Median follow-up was 41 months (range 5-95 months). Radiologic features were examined in association with both OS and DFS. The presence of central necrosis (hazard ratio (HR) 2.95, 95% CI 1.44-6.04, p = 0.029), satellite nodules (HR 3.29, 95% CI 1.35-8.02, p = 0.029), and vascular encasement (HR 2.63, 95% CI 1.28-5.41, p = 0.029) was all associated with a higher risk of death (Fig. 2) . Additionally, with each increase in axial size, the risk of death increased (HR 1.14, 95% CI 1.03-1.26, p = 0.029). No other factors were significantly associated with OS (p = 0.07-0.88); however, perpendicular axial size approached significance (HR 1.14, 95% CI 1.01-1.28, p = 0.07). In multivariate analysis, vascular encasement (HR 2.52, 95% CI 1.11-5.71, p = 0.027) and necrosis (HR 3.18, 95% CI: 1.29-7.86, p = 0.012) remained significant independent predictors of OS. The presence of satellite nodules approach significance (HR 2.57, 95% CI 0.96-6.84, p = 0.06) as well; however, axial size was not associated with OS in the multivariate model (HR 0.97, 95% CI 0.85-1.11, p = 0.64).
Similar to findings for OS, satellite nodules (HR 3.81, 95% CI 1.88-7.71, p = 0.002) and vascular encasement (HR 2.25, 95% CI 1.24-4.06, p = 0.019) were associated with reduced DFS (Fig. 3) . Additionally, with each increase in axial size, the risk of death increased (HR 1.17, 95% CI 1.07-1.28, p = 0.003) and similarly for perpendicular axial size (HR 1.17, 95% CI 1.05-1.31, p = 0.017). No other factors were significantly associated with DFS (p = 0.06-0.88); however, central necrosis approached significance (HR 1.95, 95% CI 1.07-3.54, p = 0.06). Given the strong correlation between axial size and perpendicular axial size, only axial size was included in the multivariate model. In the multivariate model, the presence of a satellite nodule (HR 2.39, 95% CI 1.02-5.60, p = 0.045) and largest axial size (HR 1.12, 95% CI 1.02-1.23, p = 0.020) remained significantly associated with DFS.
Discussion
The imaging appearance of ICC is known to be heterogeneous across patients prompting an interest in whether the phenotypic heterogeneity is predictive of biology such as tumor genetics or patient prognosis. The ability to predict tumor biology based on preoperative imaging alone could potentially benefit patient management and alter the consideration for surgery or neoadjuvant therapy. This study demonstrates an association between qualitative imaging features and survival in patients with resectable ICC. We identified that the presence of Numbers represent frequency with percent of total sample in parentheses, unless otherwise specified necrosis and vascular encasement was predictive of increased risk of death, while satellite nodule and largest axial dimension were predictive of DFS. It has previously been described that arterial enhancement of ICC on CT appears to correlate with DFS in surgically resected patients [11, 13, 14] . Our results similarly show that qualitative CT imaging features highlighting differences in enhancement patterns among resectable ICC are associated with survival. In addition to the appearance of the primary tumor itself, our results show that the presence of satellite nodules is associated with decreased diseasefree survival and approached significance with decreased overall survival in resected patients. This finding is concordant with those of Baheti et al. in a study of 92 patients with ICC demonstrating that the presence of satellite nodules and intrahepatic metastases was associated with decreased survival [23] . Radiogenomics examines associations between tumoral imaging features and their underlying cellular genetics [24] [25] [26] , with promising results emerging in many different tumors including lung, breast, brain, and renal cancers [27] [28] [29] [30] [31] . In liver imaging, a radiogenomic biomarker of microvascular invasion has been proposed for HCC [32] and Taouli et al. have recently reported a correlation between phenotypic imaging traits including infiltrative pattern, macrovascular invasion, size > 5 cm, mosaic appearance, various enhancement patterns, and genetic signatures of aggressive HCC [33] . For ICC, genetic signatures of aggressive tumor behavior are not yet definitively described but quantitative imaging phenotypes have previously been correlated with expression of specific markers of hypoxia [34] . Given the recent interest in defining the genomic landscape for ICC, we investigated whether CT imaging features could be associated with known ICC genetic mutations or pathways. Our study did not show an association between ICC imaging features and genetic mutations in our surgical patient population. ICC is a phenotypically heterogeneous tumor without clearly established genomic classifications at this time. Multiple genetic pathways have been implicated including IDH1, IDH2, KRAS, and Chromatin remodeling complex [22, 35, 36] . IDH1/2 encode metabolic enzymes for the oxidative decarboxylation of isocitrate in the Kreb cycle and have been proposed as key driver mutations in multiple cancers [35, 37] . KRAS is a proto-oncogene that has also been highlighted as a critical mutation in oncogenesis [38] . Chromatin remodeling genes regulate gene expression by p values were adjusted for multiple hypotheses using the false discovery rate correction affecting access of transcription proteins to certain portions of DNA and are among those most commonly mutated in ICC [22] . Our results show that despite a lack of associations between imaging features and genetic mutations, certain imaging features may still offer predictive information. As tumors grow larger and encase adjacent vessels, develop areas of necrosis, and spread with satellite tumors, these phenotypic differences reflect increasing biological aggressiveness. This study is a hypothesis generating study with several limitations. It was retrospective, involving a single institution and had a moderate sample size of 66 patients. However, ICC is a rare cancer limiting our ability to generate larger patient population without performing multi-center studies, which will be required to validate our results. Second, the exclusion of unresectable tumors limited the sample size, but increased the homogeneity of the study population tumors. Another limitation was the inclusion of CT studies performed at multiple institutions, using different CT scanners with varying imaging protocols, including both single-phase and multi-phase studies. These inclusion criteria kept our population as large as possible, but certain imaging features were not evaluable, such as quantitative measures of tumor enhancement that have been previously described for ICC [11] . We also excluded the evaluation of arterial phase enhancement pattern in our patients for this reason. Certain features such as fibrosis may not have been optimally evaluated in the absence of delayed imaging. Inter-reader variability in the assessment of Fig. 2 . Kaplan-Meier survival curves which illustrate that the presence of necrosis, satellite nodules, and vascular encasement were all associated with decreased survival. Fig. 3 . Kaplan-Meier survival curves which illustrate that the presence of satellite nodules and vascular encasement were associated with decreased disease-free survival.
ICC imaging features described would also need to be performed in future validation studies, preferably with uniform multiphasic imaging protocols. For our genetic analysis, our approach provides extensive analysis for over 400 cancer-associated genes, but it does not fully replace a whole genome sequencing platform. Unknown, potentially more relevant genetic pathways may not have been included; for example, Jusakul et al. have recently described new distinct subtypes of cholangiocarcinomas based on 489 cases from 10 countries [39] . Use of single tissue samples may also be a limitation given that intratumoral heterogeneity may be significant for ICC. Finally, given the moderate sample size of our patient population, limited genome sequencing performed, and the rapidly evolving field of ICC genomics, we may need to revisit the associations between CT imaging features and ICC genetic pathways in future, larger multi-center studies.
In conclusion, in this retrospective analysis, our results are consistent with prior studies and highlight the potential prognostic significance of visually assessed imaging features in resectable ICC. No association was identified between these imaging features and currently known genetic pathways in ICC. The lack of associations between imaging features and tumor genetics may reflect limitations of the genetic profiling methodology used, but may also highlight the non-redundant information within observable radiographic phenotypic variations in resectable ICC patients. 
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